Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABAA receptor is a major inhibitory neurotransmitter receptor in the mammalian central nervous system. It is an ionotropic, ligand-gated chloride channel activated by γ-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the brain. Activation of this receptor typically results in neuronal hyperpolarization and inhibition of action potential firing.
Binding of GABA opens a chloride channel, leading to hyperpolarization and reduced neuronal excitability. Allosteric modulators like benzodiazepines and barbiturates enhance this effect.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma Aminobutyric Acid Receptor A (GABAA receptor).